Steerable transseptal sheaths — the deflectable and steerable large-bore access sheaths enabling navigation within the left atrium to position structural heart devices and ablation catheters at precise anatomical targets — represent the procedural efficiency and safety improvement technology complementing transseptal needle and access sheath systems, with the Transseptal Access System Market reflecting steerable sheath technology as an important market dimension.

Agilis steerable sheath — the Abbott Agilis NxT steerable introducer sheath enabling bidirectional deflection within the left atrium to optimally position catheters at pulmonary vein ostia for AF ablation — represents the standard steerable sheath for electrophysiology transseptal procedures. The Agilis sheath's deflectable tip providing the access geometry needed for each pulmonary vein isolation approach, while the support that a steerable sheath provides for catheter manipulation in the left atrium, creates the procedural facilitation that has made steerable sheaths the standard for complex AF ablation.

Transseptal sheath design for structural heart — the large-bore steerable sheaths for MitraClip (ThinPAT and EverCross guide catheters), the Watchman FLX Access System, and procedure-specific delivery sheaths for tricuspid intervention — represent the procedure-specific large-bore steerable sheath market. The much larger inner diameter required for structural heart device delivery (fourteen to twenty-four French versus eight to ten French for ablation catheters) creating the specialized large-bore steerable sheath market with different engineering requirements from electrophysiology sheaths.

Robotic transseptal and delivery systems — the Biosense Webster Carto UNIVU and Stereotaxis magnetic navigation systems enabling remote-controlled catheter navigation from outside the radiation field — represent the emerging robotic guidance for transseptal procedures. The radiation exposure reduction for operators and the precision benefit of remote robotic catheter manipulation during complex transseptal procedures create the clinical rationale for robotic guidance adoption.

Do you think procedure-specific transseptal sheath systems will continue to proliferate as structural heart disease interventions expand to new anatomical targets, or will a smaller number of versatile steerable sheath platforms serve most structural heart and electrophysiology needs?

FAQ

What transseptal sheath systems are used for different procedures? Transseptal sheath overview by procedure: AF ablation: Agilis NxT (Abbott) — eight-point-five French; bidirectional deflection; most widely used for PVI ablation; Preface Braided (Biosense Webster/J&J) — medium deflection; LAMP system (Medtronic) — designed for Arctic Front cryoballoon navigation; SL0/SL1 non-steerable sheaths — some operators prefer non-steerable with catheter deflection alone; MitraClip (TMEER): EverCross guide catheter (Abbott) — twenty-two French; steerable; designed for MitraClip delivery; integral to MitraClip procedure kit; Watchman LAAO: Watchman Access System (Boston Scientific) — designed for Watchman FLX delivery; fourteen French; anterior-superior transseptal crossing design; LAAO-specific crossing location guidance; TAVR transseptal: various sheaths depending on procedure; Tendyne and TMVR delivery systems with dedicated guide catheters; Balloon mitral valvuloplasty: Inoue balloon catheter system includes specific transseptal sheath component; general requirements for structural sheaths: large bore for device delivery; hemostatic valve; aspiration/infusion ports; adequate support for device delivery forces; procedure-specific deflection geometry matching target anatomy.

How do transseptal access systems differ between AF ablation and structural procedures? Comparison of EP versus structural transseptal access: Electrophysiology (AF ablation): sheath size: eight to nine French (smaller); procedure goal: access to pulmonary vein ostia, posterior wall; optimal crossing location: mid-posterior fossa; single transseptal crossing standard; sheath type: steerable (Agilis, Preface) or non-steerable; ICE guidance common; conscious sedation; procedure duration two to four hours; Structural heart (MitraClip, Watchman, TMVR): sheath size: twelve to twenty-four French (much larger for device delivery); procedure goal: device delivery to mitral valve, LAA, tricuspid valve; optimal crossing location: procedure-specific (MitraClip: high posterior; LAAO: anterior-superior; TMVR: inferior); single crossing with large bore for device delivery; TEE or 3D ICE preferred for anatomy; general anesthesia typically for MitraClip and LAAO; Key differences: crossing height and position critical for structural procedures; larger bore sheath increases technical complexity and risk; device delivery through large-bore sheath has unique hemostatic and support requirements; imaging requirements higher for structural procedures from anatomical complexity.

#TransseptalAccess #SteerableSheath #AgilisSheath #StructuralHeartSheath #MitraClipAccess #WatchmanAccess